Synthesis, characterization and antimalarial evaluation
of 1H-1,2,3- triazoles-1,4-disubstituted derivatives of melatonin and tryptamine
malaria; Plasmodium Falciparum; indole; melatonin; click chemistry.
Present in more than 90 countries, malaria is considered one of the most lethal infectious
diseases in the world. Caused by parasites of the Plasmodium genus, it is transmitted by
female Anopheles mosquitoes. The most recent data on the epidemiology of the disease
released by the World Health Organization (WHO) estimate that in 2023 there were
approximately 263 million cases of malaria worldwide, with more than 597,000 deaths. The
search for new compounds with antimalarial activity is urgent, since resistance to the classic
drugs used for treatment has already been described in countries where the disease is endemic.
Melatonin is a hormone with an indole structure and plays a central role in controlling the
replication of the parasite that causes malaria and stabilizing parasitemia. Blocking the
pathway of this hormone may contribute to the discovery of new antimalarial drugs. The aim
of this work was to prepare triazoles derived from the indole nucleus that may exhibit
antimalarial activity on the parasite cell cycle, inhibiting the growth or causing the death of
Plasmodium falciparum. Several novel molecules containing in their structure, heterocyclic
1H-1,2,3-triazole rings and benzene ring with different substituents were designed and
synthesized in this work by means of the CuAAC “click chemistry” reaction catalyzed by
copper (I). In the synthesis step, the melatonin precursor was subjected to the alkylation
reaction to form the respective terminal alkyne intermediate (3). Subsequently, this
intermediate was treated with different prepared aromatic azidocompounds (1a-e) to form the
respective triazole products of the series (4a-e) derived from melatonin with yields ranging
from 68 to 91%. Tryptamine, a congener of melatonin, was also used as a precursor in the
formation of triazole sulfonamide compounds of the series (8a-e) and (11a-e) with yields
ranging from 59.4 to 91%. The structural elucidation of the intermediates and products
obtained was successfully performed using IR and NMR spectroscopic techniques of 13C and
1 H isotopes. Compounds (10), (4d) and (4e) exhibited measurable antimalarial activity with
IC50 values of 33.38 ± 1.487 µM, 31.92 ± 6.370 µM and 11.57 ± 1.863 µM, respectively,
showing low cytotoxicity in mammalian cells. Among these, (4e) emerged as the most potent
and least cytotoxic with SI (>4.32). These results highlight the potential of these three
compounds as promising candidates for further investigation, providing a solid basis for
future studies aiming at their optimization and development as antimalarial agents.